The enzymes that generate retinoic acid during development have been identi®ed as members of the aldehyde dehydrogenase (ALDH) family. The developmental expression patterns of two ALDHs that function as retinaldehyde dehydrogenases, RALDH1 and RALDH2, have been described. Here we report the cloning and expression of a third retinaldehyde dehydrogenase from the mouse called RALDH3 that shares 94% amino acid sequence identity to a human retinaldehyde dehydrogenase previously named ALDH6. In mouse embryos, RALDH3 expression is ®rst noticed in the ventral optic eminence at E8.75, then in the optic vesicle/cup, otic vesicle, and olfactory placode/pit from E9.5 to E11.5. Expression in the developing eye is primarily localized in the ventral retina, thus indicating that RALDH3 represents the V1 dehydrogenase activity described there earlier. From E8.5 to E10.5 RALDH3 expression is distinct from that of RALDH1 or RALDH2, thus indicating a unique role in sensory organ development. q
Results and discussion

Expression of RALDH3 during mouse embryogenesis
Mouse embryos possess three distinct aldehyde dehydrogenase (ALDH) enzymes able to function as retinaldehyde dehydrogenases to catalyze retinoic acid formation (McCaffery et al., 1993; Duester, 2000) . In the developing eye RALDH1 (also known as ALDH1 or AHD2) is localized in the dorsal retina from E9.5 onwards (McCaffery et al., 1991; Haselbeck et al., 1999) , RALDH2 is restricted to a brief burst of expression in the ventral optic pit/vesicle from E8.5 to E9.5 (Niederreither et al., 1997; Haselbeck et al., 1999) , and a third activity called V1 not previously characterized is localized in the ventral retina (McCaffery et al., 1993) . RALDH1 and RALDH2 are also expressed outside the developing eye suggesting functions in several aspects of retinoid signaling (Niederreither et al., 1997; Haselbeck et al., 1999) . A knockout mutation of Raldh2 results in a failure to develop beyond E8.5 and embryonic lethality by E10.5 , thus demonstrating the essential nature of this retinoic-acid generating enzyme. Human ALDH6 was initially characterized as an enzyme sharing 70% amino acid sequence identity with RALDH1 (Hsu et al., 1994) , and was later reported to function in vitro as a third retinaldehyde dehydrogenase (Yoshida et al., 1998) , i.e. RALDH3.
These three retinaldehyde dehydrogenases are most conveniently referred to by the common names RALDH1, RALDH2, and RALDH3, but there exists a new ALDH nomenclature (Vasiliou et al., 1999) periodically updated on the internet (http://www.uchsc.edu/sp/sp/alcdbase/aldhcov.html) which has provided of®cial names for all known species orthologs of the three enzymes discussed herein as indicated in parentheses: RALDH1 from human, bovine, sheep, horse, mouse, rat, chick, and Xenopus (ALDH1A1); RALDH2 from human, mouse, rat, and chick (ALDH1A2); and RALDH3 from human and mouse (ALDH1A3). Here we report the cloning and expression of the mouse ortholog of RALDH3, a third retinaldehyde dehydrogenase expressed during embryogenesis.
RALDH3 mRNA was not observed at E8.5 (data not shown), but was observed at E8.75 in the ventral portion of the optic eminence (Fig. 1A) . At E9.5 RALDH3 mRNA is observed in the optic vesicle, otic vesicle, and olfactory placode/pit (Fig. 1B ,E,F), and this pattern of expression is maintained through E10.5 and E11.5 (Fig. 1C,D) . RALDH3 is not expressed in the otic placode at E8.75 (Fig. 1A ), but is observed in the otic vesicle at E9.5 (Fig. 1F) . Expression of RALDH3 in the developing eye and nasal region is limited to the ventral retina, the retinal pigment epithelium (RPE) primordium, and the olfactory epithelium as it invaginates to form a pit (Fig. 1G) . A closer view of the developing eye from E9.5 to E11.5 shows that RALDH3 is localized in the two lips of the optic ®ssure as they are closing to form the ventral region of the optic cup (Fig. 1H±K) . Previous studies identi®ed an ALDH activity (V1) distinct from RALDH1 and RALDH2 at E9.0±E11.5 in the mouse embryonic eye (McCaffery et al., 1993) and at E12.5±E13.5 in the ventral but not dorsal retina (McCaffery et al., 1992 (McCaffery et al., , 1999 . Our ®ndings are consistent with RALDH3 being responsible for the V1 activity.
As RALDH3 expression is limited to cranial tissues at the stages examined, we compared the cranial expression patterns of RALDH3 with those of the other two retinaldehyde dehydrogenases, RALDH1 and RALDH2. At E8.5± E8.75, RALDH1 is not expressed (Fig. 2A) , whereas RALDH2 is expressed at high levels in the developing optic pit (Fig. 2D) and RALDH3 is expressed in a small region along the ventral portion of the optic eminence (Fig. 2G) . At E9.5, RALDH1 expression is now observed in the dorsal retina and mesencephalic¯exure (Fig. 2B) , RALDH2 expression is observed in the ventral optic vesicle (Fig. 2E) , and RALDH3 expression is localized in the Fig. 1 . Localization of mouse RALDH3 mRNA by whole-mount in situ hybridization. Mouse embryos were examined at E8.75 (A), E9.5 (B), E10.5 (C), and E11.5 (D). A frontal view at E9.5 (E) shows staining in both olfactory placodes. Sections of whole-mount stained embryos show RALDH3 mRNA in the otic vesicle at E9.5 (F) and the ventral retina, RPE, and olfactory epithelium at E10.5 (G). A close-up view is shown for the eye-nasal region at stages E9.5 (H,I), E10.5 (J), and E11.5 (K) where expression can be observed in the ventral retina neuroepithelium as the lips of the optic ®ssure close, in the developing RPE, and in the olfactory neuroepithelium as it is invaginating. At stage E11.5 RALDH3 mRNA can be observed in the ventral retina at the point of contact between the lips of the optic ®ssure (K). m, maxillary process; oe, optic eminence (ventral); ol, olfactory placode/pit; op, optic vesicle/cup; ot, otic vesicle; rpe, retinal pigment epithelium primordium; vr, ventral retina. ventral retina, RPE, otic vesicle, and olfactory pit (Fig. 2H) . At E10.5, expression of RALDH1 and RALDH3 is maintained as observed at E9.5 (Fig. 2C,I ), but RALDH2 expression has departed the optic vesicle and is now evident in the maxillary process (Fig. 2F) . Thus, the three enzymes display quite distinct spatiotemporal expression patterns from E8.5 to E10.5, but with a transient overlap between RALDH2 and RALDH3 in the developing ventral eye.
These studies demonstrate that RALDH3 is uniquely expressed in the ventral retina, olfactory pit, and otic vesicle. Ventral retina development is particularly sensitive to disturbances in retinoid signaling as demonstrated by retinoic acid receptor gene knockout studies (Kastner et al., 1994; Lohnes et al., 1994) . Also, there is evidence that retinoic acid is needed for development of the olfactory system (LaMantia et al., 1993) and for development of the otic vesicle to generate the inner ear (Corey and Breake®eld, 1994) . Our results point to a unique role for RALDH3 as a retinaldehyde dehydrogenase in the development of all these sensory organs.
Experimental procedures
Cloning of mouse RALDH3 cDNA
A BLAST search of GenBank identi®ed mouse EST clones with high sequence identity to the human ALDH6/ RALDH3 cDNA (accession numbers AA790530 and AA499064). These EST clones covered both the start and stop codons allowing us to design oligonucleotides in these regions as PCR primers (GAGAGTGCGAACCAGT-TATGGCTAC and CTGTTCCTCAGGGGTTCTTCTCC, respectively). As previous studies showed that human ALDH6/RALDH3 is expressed highest in the kidney (Hsu et al., 1994) , we isolated total RNA from adult mouse Fig. 2 . Comparison of RALDH3 expression (whole-mount in situ hybridization) with RALDH1 and RALDH2 expression (whole-mount immunohistochemistry) during mouse embryogenesis. ALDH1 expression is shown at E8.5 (A), E9.5 (B), and E10.5 (C). RALDH2 expression is shown at E8.5 (D), E9.5 (E), and E10.5 (F). ALDH6 expression is shown at E8.75 (G), E9.5 (H), and E10.5 (I). al, allantoic mesenchyme; m, maxillary process; mes, mesencephalic¯exure; oe, optic eminence (ventral); ol, olfactory placode/pit; op, optic vesicle/cup; ot, otic vesicle; rpe, retinal pigment epithelium primordium; s, somite. kidney and performed RT-PCR using the above primers to successfully clone and sequence a full-length mouse RALDH3 cDNA using methods previously described (Haselbeck et al., 1999) . The mouse RALDH3 cDNA isolated here (GenBank accession number AF280404) encodes a predicted 512 residue protein sharing 94% amino acid sequence identity with human ALDH6/ RALDH3, thus clearly demonstrating an orthologous relationship with the human enzyme. Mouse RALDH3 shares 70% sequence identity with mouse RALDH1 and 71% sequence identity with mouse RALDH2.
Whole-mount in situ hybridization and immunohistochemistry
Mouse embryos from E8.5 to E11.5 were subjected to whole-mount in situ hybridization (Wilkinson, 1992 ). An 800 base antisense riboprobe covering the 3 H half of the mouse RALDH3 cDNA was prepared from SP6 transcription of an ApaI digest of the plasmid containing the fulllength cDNA in pGEM-T Easy (Promega, Madison, Wisconsin). Stained embryos were embedded in 3% agarose and sectioned at 100 mm with a vibratome. Mouse embryos from E8.5 to E10.5 were subjected to whole-mount immunohistochemistry as described (Hogan et al., 1994) using speci®c antibodies against mouse RALDH1 and RALDH2 (Haselbeck et al., 1999) .
